000			01090 a2200349 4500
005			20250513150539.0
264		0	_c19981210
008			199812s 0 0 eng d
022			_a0300-0729
040			_aNLM _beng _cNLM
100	1		_aEllegård, E
245	0	0	_aNasal airflow in growth hormone treatment. _h[electronic resource]
260			_bRhinology _cJun 1998
300			_a66-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCross-Over Studies
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aGrowth Hormone _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNasal Cavity _xphysiopathology
650	0	4	_aNasal Obstruction _xdrug therapy
650	0	4	_aPeak Expiratory Flow Rate
650	0	4	_aShort Bowel Syndrome _xcomplications
650	0	4	_aTreatment Outcome
700	1		_aEllegård, L
773	0		_tRhinology _gvol. 36 _gno. 2 _gp. 66-8
999			_c9660808 _d9660808